Systemic corticosteroid treatment for seasonal allergic rhinitis: A common but poorly documented therapy
Mygind N, Laursen LC, Dahl M. Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy. Allergy 2000;55:11-5.
Aria workshop group; World health organization. Allergic rhinitis and its impact on asthma
Bousquet J, van Cauwenberge P, Khaltaev N, Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5):147-334.
Oral methylprednisolone acetate (Medrol tablets) for seasonal allergic rhinitis:examination of dose and symptom response
Brooks CD, Karl KJ, Francom SF. Oral methylprednisolone acetate (Medrol tablets) for seasonal allergic rhinitis:examination of dose and symptom response. J Clin Pharmacol 1993;33:816-22.
Seasonal allergic rhinitis and depot injection of a corticosteroid. Evaluation of the efficacy of medication early and late in the season based on detailed symptom recording
Borum P, Gronborg H, Mygind N. Seasonal allergic rhinitis and depot injection of a corticosteroid. Evaluation of the efficacy of medication early and late in the season based on detailed symptom recording. Allergy 1987;42(1):26-32.
Clinical comparison of systemic methylprednisolone acetate versus topical budesonide in patients with seasonal allergic rhinitis
Pichler WJ, Klint T, Blaser M et al. Clinical comparison of systemic methylprednisolone acetate versus topical budesonide in patients with seasonal allergic rhinitis. Allergy 1988;43:87-92.
Suppression of the hypothalamic-pituitary-adrenal axis after a single intra-muscular injection of methylprednisolone acetate
Hedner P, Persson G. Suppression of the hypothalamic-pituitary-adrenal axis after a single intra-muscular injection of methylprednisolone acetate. Ann Allerg 1981;47:176-9.